The expression of CD5 on B-cell neoplasms is classically indicative of chronic lymphocytic leukemia (CLL), an indolent neoplasm, or mantle cell lymphoma (MCL), a usually aggressive lymphoma [9]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.